This week has brought further validation to psychedelic research and medicine, with the University of Wisconsin-Madison set to enroll its first cohort of students on a psychedelics-related Master’s Program in pharmaceutical sciences. According to the University’s announcement: The fully online program will equip graduates to be future leaders in the field of therapeutic development and deployment…


Previous articleEarly Clinical Research History of DMT
Next articleChampignon Brands Announces Filing of Listing Statement